Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targeting
- PMID: 8841950
- DOI: 10.1007/BF00210632
Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targeting
Abstract
Gene therapy is used to correct genetic defects or to deliver new therapeutic functions to the target cells. Viral vectors are employed mainly as a gene delivery system. A great variety of viral expression systems have been developed and assessed for their ability to transfer genes into somatic cells. In particular, retroviral and adenoviral mediated gene transfer have been extensively studied and improved. Preclinical and clinical studies covering a large range of genetic disorders are currently underway to solve basic issues dealing with gene transfer efficiencies, regulation of gene expression, and potential risks of the use of viral vectors. The majority of clinical gene therapy trials that employ viral vectors perform exvivo gene transfer into target cells. The main issue in potential clinical application of gene therapy is the need for increased gene transfer efficiency and target specificity associated with regulated gene expression at therapeutically relevant levels in vivo. Gene regulatory elements, such as promoters and enhancers, possess cell type specific activities and can be activated by certain induction factors (e.g., hormones, growth factors, cytokines, cytostatics, irradiation, heat shock) via responsive elements. A controlled and restricted expression of these genes can be achieved using such regulatory elements as internal promoters to drive the expression of therapeutic genes in viral vector constructs. In addition to high level and efficient gene expression, minimizing or excluding inappropriate gene expression in surrounding nontarget cells is of great importance for numerous gene therapeutic approaches. This contribution furnishes insight into the field of cell type specific promoter and enhancer systems which have been used for targeted and inducible expression of therapeutic genes in certain genetic disorders, viral infections, and malignancies. We also discuss promoters that represent attractive candidates for the construction of viral vectors.
Similar articles
-
Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo.FASEB J. 1997 Jul;11(8):624-34. doi: 10.1096/fasebj.11.8.9240964. FASEB J. 1997. PMID: 9240964 Review.
-
[Gene therapy: new developments].Praxis (Bern 1994). 2002 Dec 18;91(51-52):2227-35. doi: 10.1024/0369-8394.91.51.2227. Praxis (Bern 1994). 2002. PMID: 12564039 Review. German.
-
Chimeric smooth muscle-specific enhancer/promoters: valuable tools for adenovirus-mediated cardiovascular gene therapy.Circ Res. 2001 Mar 16;88(5):468-75. doi: 10.1161/01.res.88.5.468. Circ Res. 2001. PMID: 11249869
-
Targeting of retroviral vectors for gene therapy.Hum Gene Ther. 1993 Apr;4(2):129-41. doi: 10.1089/hum.1993.4.2-129. Hum Gene Ther. 1993. PMID: 8494923 Review.
-
Retroviral and transposon-based tet-regulated all-in-one vectors with reduced background expression and improved dynamic range.Hum Gene Ther. 2011 Feb;22(2):166-76. doi: 10.1089/hum.2010.099. Epub 2010 Dec 19. Hum Gene Ther. 2011. PMID: 20825282
Cited by
-
Cell targeting in anti-cancer gene therapy.Malays J Med Sci. 2004 Jan;11(1):9-23. Malays J Med Sci. 2004. PMID: 22977356 Free PMC article.
-
Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy.Pharm Res. 2006 Jun;23(6):1053-74. doi: 10.1007/s11095-006-0164-2. Epub 2006 May 26. Pharm Res. 2006. PMID: 16715361 Review.
-
Lipid-based nucleic acid therapeutics with in vivo efficacy.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Mar;15(2):e1856. doi: 10.1002/wnan.1856. Epub 2022 Sep 30. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023. PMID: 36180107 Free PMC article. Review.
-
DNA-based therapeutics and DNA delivery systems: a comprehensive review.AAPS J. 2005 Apr 8;7(1):E61-77. doi: 10.1208/aapsj070109. AAPS J. 2005. PMID: 16146351 Free PMC article. Review.
-
Viral vectors for gene transfer: a review of their use in the treatment of human diseases.Drugs. 2000 Aug;60(2):249-71. doi: 10.2165/00003495-200060020-00002. Drugs. 2000. PMID: 10983732 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical